Role of biochemical markers in the monitoring of COVID-19 patients.
J Med Biochem
; 40(2): 115-128, 2021 Mar 12.
Article
in English
| MEDLINE | ID: covidwho-1150902
ABSTRACT
COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
J Med Biochem
Year:
2021
Document Type:
Article
Affiliation country:
Jomb0-29341
Similar
MEDLINE
...
LILACS
LIS